ENTPD1 and neoplasm: We used flow cytometry to test CD39 expression on antigen-challenged MSLN CAR-T cells, and the results revealed that MSLN CAR-T cells cocultured with MSLN-positive tumor cells also upregulated CD39 expression (Figure 4H Figures S8A and S8C).